Park Ha Biological Technology Co., Ltd.
PHH
$0.4785
$0.00050.11%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.77M | 2.58M | 2.38M | 2.16M | 1.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.77M | 2.58M | 2.38M | 2.16M | 1.94M |
| Cost of Revenue | 155.80K | 175.60K | 195.40K | 239.80K | 284.20K |
| Gross Profit | 2.61M | 2.40M | 2.19M | 1.92M | 1.66M |
| SG&A Expenses | 21.58M | 11.47M | 1.36M | 1.19M | 1.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.78M | 11.69M | 1.59M | 1.47M | 1.34M |
| Operating Income | -19.01M | -9.11M | 793.80K | 696.00K | 598.20K |
| Income Before Tax | -18.96M | -9.08M | 793.40K | 695.30K | 597.20K |
| Income Tax Expenses | 449.40K | 382.10K | 314.80K | 255.50K | 196.20K |
| Earnings from Continuing Operations | -19.41 | -9.46 | 0.48 | 0.44 | 0.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.41M | -9.46M | 478.60K | 439.90K | 401.20K |
| EBIT | -19.01M | -9.11M | 793.80K | 696.00K | 598.20K |
| EBITDA | -18.99M | -9.09M | 816.40K | 717.90K | 619.40K |
| EPS Basic | -0.72 | -0.35 | 0.02 | 0.02 | 0.02 |
| Normalized Basic EPS | -0.44 | -0.21 | 0.02 | 0.02 | 0.02 |
| EPS Diluted | -0.72 | -0.35 | 0.02 | 0.02 | 0.02 |
| Normalized Diluted EPS | -0.44 | -0.21 | 0.02 | 0.02 | 0.02 |
| Average Basic Shares Outstanding | 103.77M | 101.89M | 100.00M | 100.00M | 100.00M |
| Average Diluted Shares Outstanding | 103.77M | 101.89M | 100.00M | 100.00M | 100.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |